247923-30-4

Upstream product

• 23877-12-5 tert-butyl bromoisobutyrate 
• 106-53-6 para-bromobenzenethiol 

Downstream Products

• 265129-65-5 2-{4-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-vinyl]-phenylsulfanyl}-2-methyl-propionic acid tert-butyl ester 
• 409097-33-2 tert-butyl 2-[(4-formylphenyl)sulphanyl]-2-methylpropanoate 
• 265129-78-0 t-Butyl 2-(4-(2-(1-Heptyl-3-(2,4-difluorophenyl)ureido)ethyl)phenylthio)-2-methylpropionate 
• 247923-31-5 2-{4-[2-(1,3-dioxo-1,3-dihydroisoindol-2-yl)ethyl]pheylsulfanyl}-2-methylpropionic acid tert-butyl ester 
• 247923-32-6 t-Butyl N-Heptanoyl-2-(4-(2-aminoethyl)phenylthio)-2-methylpropionate 
• 247923-33-7 1,1-dimethylethyl 2-[[4-(2-aminoethyl)phenyl]thio]-2-methyl-propanoate 

Relevant academic research and scientific papers

1,2,4-Triazine Derivatives, Preparation and Use Thereof in Human Therapy

The invention concerns 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives of general formula (I), wherein: R1 and R2, identical or different, represent a branched or linear C1-C7 alkyl or alkenyl radical, a C1/s

Propionic acid derivatives

The present application relates to novel potent PPAR-alpha-activating compounds for treating, for example, coronary heart disease, and to their preparation.